(Updated with closing stock prices.)
Johnson & Johnson
about $1.7 billion according to a the ruling in a
patent infringement suit
regarding Abbott's Humira and J&J's Centocor, which both treat rheumatoid arthritis.
On Tuesday, Abbott closed down 78 cents, or 1.6%, at $47.04.
, a Belgium industrial company, is close to purchasing a stake in
Opel division after
reports that the deal could be settled in a matter of days.
reported third-quarter earnings of $201.1 million, or $1.26 a share, up 45% from the same quarter last year, after an
. Revenue also increased, by 26% to $1.05 billion.
On Tuesday, Apollo gained $5.13, or 7.8%, to close at $71.12.
, Barclays upgraded
to overweight from equalweight with a $71 price target, while Merrill Lynch/Bank of America upgraded
to buy from neutral with a $26 price target.
FedEx closed down a penny at $55.62 on Tuesday, while Electronic Arts added 91 cents to $21.72.
With this in mind, we thought we'd take a look at some of the stocks in the news and see what Jim Cramer's had to say about them lately.
To read more,
Stockpickr is a wholly owned subsidiary of TheStreet.com.